We have criticised the Scottish Medicines Consortium's (SMC) decision not to recommend abiraterone for use on the NHS in Scotland. It follows the National Institute for Health and Clinical Excellence's (NICE) draft decision to deny the drug for men on the NHS in England and Wales.

Read more